Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001179110-12-012016
Filing Date
2012-07-31
Accepted
2012-07-31 12:40:43
Documents
1
Period of Report
2012-07-30

Document Format Files

Seq Description Document Type Size
1 FORM 4 - edgar.html 4  
1 FORM 4 - edgar.xml 4 7270
  Complete submission text file 0001179110-12-012016.txt   8654
Mailing Address MORRIS CORPORATE CENTER III 400 INTERPACE PARKWAY PARSIPPANY NJ 07054
Business Address MORRIS CORPORATE CENTER III 400 INTERPACE PARKWAY PARSIPPANY NJ 07054 9092701400
WATSON PHARMACEUTICALS INC (Issuer) CIK: 0000884629 (see all company filings)

EIN.: 953872914 | State of Incorp.: NV | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations

Mailing Address 800 SCUDDERS MILL ROAD PRINCETON NJ 08536
Business Address
WEISS FRED G (Reporting) CIK: 0001081534 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-13305 | Film No.: 12996121